Comparison

Dalbavancin HCl

Manufacturer TargetMol
Category
Type Molecules
Specific against other
Amount 50mg
Item no. TMO-T21358-50mg
Approximate Leadtime 1-2 Weeks
eClass 6.1 32169090
eClass 9.0 32169090
Available
purity
98.00%
formula
C88H101Cl3N10O28
MolWt
1853.17
Pathway
Microbiology/Virology
Target
Antibiotic
Bioactivity
Dalbavancin, a novel second-generation lipoglycopeptide antibiotic, possesses in vitro activity against a variety of Gram-positive pathogens including methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-resistant Staphylococcus epidermidis (MRSE), Dalbavancin hydrochloride inhibits Staphylococcus aureus and Bacillus anthracis with MIC90s of 0.06 ug/mL and 0.25 ug/mL, respectively
Reference
Scoble PJ, Owens RC Jr, Puttagunta S, Yen M, Dunne MW. Pharmacokinetics, Safety, and Tolerability of a Single 500-mg or 1000-mg Intravenous Dose of Dalbavancin in Healthy Japanese Subjects. Clin Drug Investig. 2015 Oct 12. [Epub ahead of print] PubMed PMID: 26458939.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

Amount: 50mg
Available: In stock
available

Compare

Add to wishlist

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close